Clinical Trial Update: Effectiveness and Safety of Silodosin in the Treatment of Benign Prostatic Hyperplasia [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated the effectiveness and safety of silodosin for benign prostatic hyperplasia and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Silodosin (Silodosin)

Snippet

Sponsor: RECORDATI GROUP | Conditions: Benign Prostatic Hyperplasia | Phase 4 | Status: COMPLETED